Concepedia

Author

Sepideh Saadatmand

Radboud University Nijmegen

Also Known As

Sepideh Saadatmand

22

Publications

1.1K

Citations

11

H-Index

31

Concepts

All Affiliations

Radboud University NijmegenThe Netherlands Cancer InstituteUniversity Medical Center GroningenLeiden University Medical CenterErasmus MC Cancer Institute
SS

About

Sepideh Saadatmand is an author at Radboud University Nijmegen specializing in medicine, radiation oncology, and breast cancer.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

401

2

Health Sciences

1

1

168

3

Public Health

1

1

15

4

Immunology

1

1

59

5

Obstetrics

1

1

168

Sepideh Saadatmand

×

9

Publications

947

Citations

9

H-Index

YearCitations

Influence of tumour stage at breast cancer detection on survival in modern times: population based study in 173 797 patients

Sepideh Saadatmand, Reini Bretveld, Sabine Siesling,

BMJ

2015

317

MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial

Sepideh Saadatmand, H. Amarens Geuzinge, Emiel J. Rutgers,

The Lancet Oncology

2019

168

Breast conserving therapy and mastectomy revisited: Breast cancer‐specific survival and the influence of prognostic factors in 129,692 patients

Mirelle Lagendijk, Marissa C. van Maaren, Sepideh Saadatmand,

International Journal of Cancer

2017

159

Survival benefit in women with <i>BRCA1</i> mutation or familial risk in the <scp>MRI</scp> screening study (<scp>MRISC</scp>)

Sepideh Saadatmand, Inge‐Marie Obdeijn, Emiel J. Rutgers,

International Journal of Cancer

2015

95

Cost-Effectiveness of Screening Women With Familial Risk for Breast Cancer With Magnetic Resonance Imaging

Sepideh Saadatmand, Madeleine M.A. Tilanus‐Linthorst, Emiel J. Rutgers,

JNCI Journal of the National Cancer Institute

2013

64

Addition of interferon‐α to the p53‐SLP® vaccine results in increased production of interferon‐γ in vaccinated colorectal cancer patients: A phase I/II clinical trial

Eliane C.M. Zeestraten, Frank M. Speetjens, Marij J.P. Welters,

International Journal of Cancer

2012

59

Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk

H. Amarens Geuzinge, Inge-Marie Obdeijn, Emiel J. Rutgers,

JAMA Oncology

2020

51

Breast density as indicator for the use of mammography or MRI to screen women with familial risk for breast cancer (FaMRIsc): a multicentre randomized controlled trial

Sepideh Saadatmand, Emiel J. Rutgers, RobAEM Tollenaar,

BMC Cancer

2012

19

Relevance and efficacy of breast cancer screening in<i>BRCA1</i>and<i>BRCA2</i>mutation carriers above 60 years: A national cohort study

Sepideh Saadatmand, Janet R. Vos, Maartje J. Hooning,

International Journal of Cancer

2014

15

Page 1